The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients
Status
Conditions
Treatments
Details and patient eligibility
About
The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients
Full description
This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications.
Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured.
Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months.
The study will include the development, validation and the testing for evaluating the specially designed mobile application.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Stages 2-5 of chronic kidney disease
- Literate
- Ownership of android smart phone compatible with the application
- Poly-pharmacy
Exclusion criteria
- On dialysis due to loss of kidney function
- Pregnancy due to altered physiology
Trial design
Primary purpose
Allocation
Interventional model
Masking
86 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Shaza Gamal, Bsc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal